China Alzheimer's Disease Drug Market Research Report 2018

Publisher Name :
Date: 15-Feb-2018
No. of pages: 97
Inquire Before Buying

The global Alzheimer's Disease Drug market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Alzheimer's Disease Drug development status and future trend in China, focuses on top players in China, also splits Alzheimer's Disease Drug by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

- Allergan

- Eisai

- Novartis

- Daiichi Sankyo

- Merz Pharma

- Pfizer

- Johnson & Johnson

- Lundbeck

Geographically, this report splits the China market into six regions,

- South China

- East China

- Southwest China

- Northeast China

- North China

- Central China

- Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

- Donepezil

- Memantine

- Rivastigmine

On the basis of the end users/application, this report covers

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

China Alzheimer's Disease Drug Market Research Report 2018

Table of Contents
China Alzheimer's Disease Drug Market Research Report 2017
1 Alzheimer's Disease Drug Overview
1.1 Product Overview and Scope of Alzheimer's Disease Drug
1.2 Classification of Alzheimer's Disease Drug by Product Category
1.2.1 China Alzheimer's Disease Drug Sales (K Units) Comparison by Type (2012-2022)
1.2.2 China Alzheimer's Disease Drug Sales (K Units) Market Share by Type in 2016
1.2.3 Donepezil
1.2.4 Memantine
1.2.5 Rivastigmine
1.3 China Alzheimer's Disease Drug Market by Application/End Users
1.3.1 China Alzheimer's Disease Drug Sales (K Units) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 China Alzheimer's Disease Drug Market by Region
1.4.1 China Alzheimer's Disease Drug Market Size (Million USD) Comparison by Region (2012-2022)
1.4.2 South China Alzheimer's Disease Drug Status and Prospect (2012-2022)
1.4.3 East China Alzheimer's Disease Drug Status and Prospect (2012-2022)
1.4.4 Southwest China Alzheimer's Disease Drug Status and Prospect (2012-2022)
1.4.5 Northeast China Alzheimer's Disease Drug Status and Prospect (2012-2022)
1.4.6 North China Alzheimer's Disease Drug Status and Prospect (2012-2022)
1.4.7 Central China Alzheimer's Disease Drug Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Alzheimer's Disease Drug (2012-2022)
1.5.1 China Alzheimer's Disease Drug Sales (K Units) and Growth Rate (%)(2012-2022)
1.5.2 China Alzheimer's Disease Drug Revenue (Million USD) and Growth Rate (%)(2012-2022)
2 China Alzheimer's Disease Drug Market Competition by Players/Manufacturers
2.1 China Alzheimer's Disease Drug Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Alzheimer's Disease Drug Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Alzheimer's Disease Drug Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.4 China Alzheimer's Disease Drug Market Competitive Situation and Trends
2.4.1 China Alzheimer's Disease Drug Market Concentration Rate
2.4.2 China Alzheimer's Disease Drug Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Alzheimer's Disease Drug Manufacturing Base Distribution, Sales Area, Product Types
3 China Alzheimer's Disease Drug Sales and Revenue by Region (2012-2017)
3.1 China Alzheimer's Disease Drug Sales (K Units) and Market Share by Region (2012-2017)
3.2 China Alzheimer's Disease Drug Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Alzheimer's Disease Drug Price (USD/Unit) by Regions (2012-2017)
4 China Alzheimer's Disease Drug Sales and Revenue by Type/ Product Category (2012-2017)
4.1 China Alzheimer's Disease Drug Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
4.2 China Alzheimer's Disease Drug Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Alzheimer's Disease Drug Price (USD/Unit) by Type (2012-2017)
4.4 China Alzheimer's Disease Drug Sales Growth Rate (%) by Type (2012-2017)
5 China Alzheimer's Disease Drug Sales by Application (2012-2017)
5.1 China Alzheimer's Disease Drug Sales (K Units) and Market Share by Application (2012-2017)
5.2 China Alzheimer's Disease Drug Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 China Alzheimer's Disease Drug Players/Suppliers Profiles and Sales Data
6.1 Allergan
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Alzheimer's Disease Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Allergan Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.1.4 Main Business/Business Overview
6.2 Eisai
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Alzheimer's Disease Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Eisai Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.2.4 Main Business/Business Overview
6.3 Novartis
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Alzheimer's Disease Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Novartis Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.3.4 Main Business/Business Overview
6.4 Daiichi Sankyo
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Alzheimer's Disease Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.4.4 Main Business/Business Overview
6.5 Merz Pharma
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Alzheimer's Disease Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Merz Pharma Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.5.4 Main Business/Business Overview
6.6 Pfizer
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Alzheimer's Disease Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Pfizer Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.6.4 Main Business/Business Overview
6.7 Johnson & Johnson
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Alzheimer's Disease Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Johnson & Johnson Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.7.4 Main Business/Business Overview
6.8 Lundbeck
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Alzheimer's Disease Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Lundbeck Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.8.4 Main Business/Business Overview
7 Alzheimer's Disease Drug Manufacturing Cost Analysis
7.1 Alzheimer's Disease Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Alzheimer's Disease Drug
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Alzheimer's Disease Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Alzheimer's Disease Drug Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Alzheimer's Disease Drug Market Size (Sales and Revenue) Forecast (2017-2022)
11.1 China Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 China Alzheimer's Disease Drug Sales (K Units) Forecast by Type (2017-2022)
11.3 China Alzheimer's Disease Drug Sales (K Units) Forecast by Application (2017-2022)
11.4 China Alzheimer's Disease Drug Sales (K Units) Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Alzheimer's Disease Drug Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Alzheimer's Disease Drug Sales (K Units) by Application (2016-2022)
Figure Product Picture of Alzheimer's Disease Drug
Table China Alzheimer's Disease Drug Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Alzheimer's Disease Drug Sales Volume Market Share by Types in 2016
Figure Donepezil Product Picture
Figure Memantine Product Picture
Figure Rivastigmine Product Picture
Figure China Alzheimer's Disease Drug Sales (K Units) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Alzheimer's Disease Drug by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure South China Alzheimer's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Alzheimer's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Alzheimer's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Alzheimer's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Alzheimer's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Alzheimer's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Alzheimer's Disease Drug Sales (K Units) and Growth Rate (%)(2012-2022)
Figure China Alzheimer's Disease Drug Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Alzheimer's Disease Drug Sales of Key Players/Manufacturers (2012-2017)
Table China Alzheimer's Disease Drug Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Alzheimer's Disease Drug Sales Share (%) by Players/Manufacturers
Figure 2017 China Alzheimer's Disease Drug Sales Share (%) by Players/Manufacturers
Table China Alzheimer's Disease Drug Revenue by Players/Manufacturers (2012-2017)
Table China Alzheimer's Disease Drug Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Alzheimer's Disease Drug Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Alzheimer's Disease Drug Revenue Market Share (%) by Players/Manufacturers
Table China Market Alzheimer's Disease Drug Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Alzheimer's Disease Drug Average Price of Key Players/Manufacturers in 2016
Figure China Alzheimer's Disease Drug Market Share of Top 3 Players/Manufacturers
Figure China Alzheimer's Disease Drug Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Alzheimer's Disease Drug Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Alzheimer's Disease Drug Product Category
Table China Alzheimer's Disease Drug Sales (K Units) by Regions (2012-2017)
Table China Alzheimer's Disease Drug Sales Share (%) by Regions (2012-2017)
Figure China Alzheimer's Disease Drug Sales Share (%) by Regions (2012-2017)
Figure China Alzheimer's Disease Drug Sales Market Share (%) by Regions in 2016
Table China Alzheimer's Disease Drug Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Alzheimer's Disease Drug Revenue Market Share (%) by Regions (2012-2017)
Figure China Alzheimer's Disease Drug Revenue Market Share (%) by Regions (2012-2017)
Figure China Alzheimer's Disease Drug Revenue Market Share (%) by Regions in 2016
Table China Alzheimer's Disease Drug Price (USD/Unit) by Regions (2012-2017)
Table China Alzheimer's Disease Drug Sales (K Units) by Type (2012-2017)
Table China Alzheimer's Disease Drug Sales Share (%) by Type (2012-2017)
Figure China Alzheimer's Disease Drug Sales Share (%) by Type (2012-2017)
Figure China Alzheimer's Disease Drug Sales Market Share (%) by Type in 2016
Table China Alzheimer's Disease Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Alzheimer's Disease Drug Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Alzheimer's Disease Drug by Type (2012-2017)
Figure Revenue Market Share of Alzheimer's Disease Drug by Type in 2016
Table China Alzheimer's Disease Drug Price (USD/Unit) by Types (2012-2017)
Figure China Alzheimer's Disease Drug Sales Growth Rate (%) by Type (2012-2017)
Table China Alzheimer's Disease Drug Sales (K Units) by Applications (2012-2017)
Table China Alzheimer's Disease Drug Sales Market Share (%) by Applications (2012-2017)
Figure China Alzheimer's Disease Drug Sales Market Share (%) by Application (2012-2017)
Figure China Alzheimer's Disease Drug Sales Market Share (%) by Application in 2016
Table China Alzheimer's Disease Drug Sales Growth Rate (%) by Application (2012-2017)
Figure China Alzheimer's Disease Drug Sales Growth Rate (%) by Application (2012-2017)
Table Allergan Alzheimer's Disease Drug Basic Information List
Table Allergan Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Allergan Alzheimer's Disease Drug Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Allergan Alzheimer's Disease Drug Sales Market Share (%) in China (2012-2017)
Figure Allergan Alzheimer's Disease Drug Revenue Market Share (%) in China (2012-2017)
Table Eisai Alzheimer's Disease Drug Basic Information List
Table Eisai Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Eisai Alzheimer's Disease Drug Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Eisai Alzheimer's Disease Drug Sales Market Share (%) in China (2012-2017)
Figure Eisai Alzheimer's Disease Drug Revenue Market Share (%) in China (2012-2017)
Table Novartis Alzheimer's Disease Drug Basic Information List
Table Novartis Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Novartis Alzheimer's Disease Drug Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Novartis Alzheimer's Disease Drug Sales Market Share (%) in China (2012-2017)
Figure Novartis Alzheimer's Disease Drug Revenue Market Share (%) in China (2012-2017)
Table Daiichi Sankyo Alzheimer's Disease Drug Basic Information List
Table Daiichi Sankyo Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Daiichi Sankyo Alzheimer's Disease Drug Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Daiichi Sankyo Alzheimer's Disease Drug Sales Market Share (%) in China (2012-2017)
Figure Daiichi Sankyo Alzheimer's Disease Drug Revenue Market Share (%) in China (2012-2017)
Table Merz Pharma Alzheimer's Disease Drug Basic Information List
Table Merz Pharma Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Merz Pharma Alzheimer's Disease Drug Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Merz Pharma Alzheimer's Disease Drug Sales Market Share (%) in China (2012-2017)
Figure Merz Pharma Alzheimer's Disease Drug Revenue Market Share (%) in China (2012-2017)
Table Pfizer Alzheimer's Disease Drug Basic Information List
Table Pfizer Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Pfizer Alzheimer's Disease Drug Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Pfizer Alzheimer's Disease Drug Sales Market Share (%) in China (2012-2017)
Figure Pfizer Alzheimer's Disease Drug Revenue Market Share (%) in China (2012-2017)
Table Johnson & Johnson Alzheimer's Disease Drug Basic Information List
Table Johnson & Johnson Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Johnson & Johnson Alzheimer's Disease Drug Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Johnson & Johnson Alzheimer's Disease Drug Sales Market Share (%) in China (2012-2017)
Figure Johnson & Johnson Alzheimer's Disease Drug Revenue Market Share (%) in China (2012-2017)
Table Lundbeck Alzheimer's Disease Drug Basic Information List
Table Lundbeck Alzheimer's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Lundbeck Alzheimer's Disease Drug Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Lundbeck Alzheimer's Disease Drug Sales Market Share (%) in China (2012-2017)
Figure Lundbeck Alzheimer's Disease Drug Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alzheimer's Disease Drug
Figure Manufacturing Process Analysis of Alzheimer's Disease Drug
Figure Alzheimer's Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Alzheimer's Disease Drug Major Players/Manufacturers in 2016
Table Major Buyers of Alzheimer's Disease Drug
Table Distributors/Traders List
Figure China Alzheimer's Disease Drug Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Alzheimer's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Alzheimer's Disease Drug Price (USD/Unit) Trend Forecast (2017-2022)
Table China Alzheimer's Disease Drug Sales (K Units) Forecast by Type (2017-2022)
Figure China Alzheimer's Disease Drug Sales (K Units) Forecast by Type (2017-2022)
Figure China Alzheimer's Disease Drug Sales Volume Market Share Forecast by Type in 2022
Table China Alzheimer's Disease Drug Sales (K Units) Forecast by Application (2017-2022)
Figure China Alzheimer's Disease Drug Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Alzheimer's Disease Drug Sales Volume Market Share Forecast by Application in 2022
Table China Alzheimer's Disease Drug Sales (K Units) Forecast by Regions (2017-2022)
Table China Alzheimer's Disease Drug Sales Volume Share Forecast by Regions (2017-2022)
Figure China Alzheimer's Disease Drug Sales Volume Share Forecast by Regions (2017-2022)
Figure China Alzheimer's Disease Drug Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Alzheimer's Disease Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 22-Jun-2018        Price: US 3480 Onwards        Pages: 133
    Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Scope of the Report: This report focuses on the Alzheimer's Disease Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and applicatio......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Alzheimer's Disease Drug Market 2018, Forecast to 2023
    Published: 22-Jun-2018        Price: US 4880 Onwards        Pages: 136
    Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Scope of the Report: This report focuses on the Alzheimer's Disease Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and applicatio......
  • Investigation Report on Nicergoline in China, 2018-2022
    Published: 21-Jun-2018        Price: US 2200 Onwards        Pages: 30
    Description Nicergoline is a semi-synthetic ergoline derivative that plays as a-blocker and can strengthen vascular systems, brain cell metabolism, oxygen and glucose digestion and dopamine conversion so that nerve conduction and brain function can be improved. Nicergoline was originally developed by Pfizer. It can be applied to a wide range of symptoms, so it became popular worldwide since its launch. According to CRI's analysis, due to the expired patent of nicer......
  • 2018-2023 Global Alzheimer's Disease Consumption Market Report
    Published: 11-Jun-2018        Price: US 4660 Onwards        Pages: 132
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Alzheimer's Disease market for 2018-2023. Alzheimer's disease is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60-70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss). Over the next five years, LPI(LP Information) projects......
  • 2018 Top 5 Alzheimer's Disease Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 11-Jun-2018        Price: US 4960 Onwards        Pages: 124
    Alzheimer's disease is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60-70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss). Over the next five years, LPI(LP Information) projects that Alzheimer's Disease will register a 15.5% CAGR in terms of revenue, reach US$ 6880 million by 2023, from US$ 2900 million in 2017. This report studies the global ......
  • United States Alzheimer's Disease Drug Market Report 2018
    Published: 07-Jun-2018        Price: US 3800 Onwards        Pages: 98
    In this report, the United States Alzheimer's Disease Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth......
  • 2018-2023 Global Alzheimer's Disease Drug Consumption Market Report
    Published: 06-Jun-2018        Price: US 4660 Onwards        Pages: 135
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Alzheimer's Disease Drug market for 2018-2023. Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. In the last several years, global market of alzheimer's disease drug change huge. The class......
  • 2018 Top 5 Alzheimer's Disease Drug Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 06-Jun-2018        Price: US 4960 Onwards        Pages: 125
    Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. In the last several years, global market of alzheimer's disease drug change huge. The classification of alzheimer's disease drug includes Memantine, Donepezil, Rivastigmine and Others, and the proportion of Memantine in 2016 is about 49.28%. The market for Donepezil, is decreast......
  • Global Alzheimer's Disease Drug Sales Market Report 2018
    Published: 04-Jun-2018        Price: US 4000 Onwards        Pages: 108
    This report studies the global Alzheimer's Disease Drug market status and forecast, categorizes the global Alzheimer's Disease Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs